139 MR-guided adaptive stereotactic ablative body radiotherapy (MRgSABR) in thoracic tumours

Stereotactic-ablative body radiotherapy (SABR) is an effective modality for early-stage lung cancer and thoracic metastases. However, target motion, ultra-central/central location and respiratory comorbidity compromise optimal dose delivery. MR-guided-SABR (MRgSABR) provides real-time tracking and daily-adaptation, allowing higher doses compared to conventional-SABR. This may improve local control (LC), progression-free survival (PFS), and overall survival (OS) while applying an isotoxic approach.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Elena Moreno-Olmedo, Ben George, David Woolf, John Conibear, Andy Gaya, Kasia Owczarczyk, Luis Aznar, Joss Adams, Veni Ezhil, Timothy Sevitt, Peter Dickinson, Kevin Franks, Alex Martin, Philip Camilleri, James Good, Crispin Hiley Tags: Radiotherapy Source Type: research